The Schulte Group - Systems Biology of Cancer
The Schulte Group investigates therapy options arising from the nucleolar stress response.
Research themes
About
The Schulte Group is dedicated to advance human health by trans- and interdisciplinary research in Indigenous genome sciences, cancer biology, and Space health.
The Schulte Group pursues its research interests in three major collaborations
- In collaboration with the National Centre for Indigenous Genomics NCIG: Advancing health equity for Indigenous Australians through pharmacogenomics: building an end-to-end discovery pipeline. Category 1 funded by the MRFF 2023-2026, 2025085; CIA Schulte.
- In collaboration with the ANU Institute of Space (InSpace): Microwearables for Space. Category 2 funded by a Trailblazer Universities Fund from the Department of Education DESE an industry partners under the iLAuNCH scheme 2023-2027; CIA Schulte
- Therapeutic vulnerabilities at the nucleolar stress response in fusion gene driven sarcoma. A collaboration with the Hannan Group at JCSMR. Category 3 funded by the Max Lindemann Memorial Foundation, Miami 2021-2027; CIA Schulte.
More information
Members
Leader
Professor
Researcher
Research Fellow
Collaborator
Associate Director, Research Infrastructure, JCSMR
Senior Fellow / Group Leader
Collaborator
Centre Director, The National Centre for Indigenous Genomics
Senior Fellow
Director, The John Curtin School of Medical Research
Center Director, The National Platelet Research and Referral Centre
Lead, ANU Centre for Therapeutic Discovery (ACTD)
Associate Professor in Pharmacogenomic Technologies
Group Leader
Group Leader
Deputy Dean, Research, CHM
NHMRC Principle Res. Fellow
Senior Fellow
Deputy Director - National Center for Indigenous Genomics
Research Fellow - NCIG BioLead